Veritas Asset Management’s ResMed RMD Stock Holding History

Veritas Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-100,000	Closed	-$6.32M	–	33
2016 Q2	$6.32M	Buy	+100,000	New	+$5.89M	0.07%	25
2015 Q3	–	Sell	-120,000	Closed	-$6.76M	–	29
2015 Q2	$6.76M	Sell	120,000 -60,000	-33%	-$3.79M	0.1%	22
2015 Q1	$12.9M	Hold	180,000	–	–	0.2%	18
2014 Q4	$10.1M	Sell	180,000 -95,000	-35%	-$4.96M	0.16%	18
2014 Q3	$13.5M	Buy	275,000 +50,000	+22%	+$2.55M	0.22%	19
2014 Q2	$11.4M	Hold	225,000	–	–	0.19%	18
2014 Q1	$10.1M	Buy	225,000 +25,000	+13%	+$1.12M	0.18%	19
2013 Q4	$9.42M	Buy	200,000 +100,000	+100%	+$5.06M	0.19%	20
2013 Q3	$5.28M	Buy	+100,000	New	+$4.85M	0.13%	21

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Veritas Asset Management's RMD Position: Q3 2016 in Review

Veritas Asset Management sold out of ResMed (RMD) in Q3 2016, closing a stake of 100,000 shares — an estimated $6.32M sold.

Veritas Asset Management first reported a position in RMD in Q3 2013 and held it in 9 quarters. The position peaked at $13.5M in Q3 2014. 373 funds tracked by Wall St. Rank hold RMD as of Q3 2016.

Veritas Asset Management reported no remaining ResMed position as of Q3 2016 after selling out during the quarter.
Veritas Asset Management sold 100,000 ResMed shares in Q3 2016, an estimated $6.32M.
Veritas Asset Management first reported a position in ResMed in Q3 2013 and held it in 9 quarters.
Veritas Asset Management's ResMed position peaked at $13.5M in Q3 2014.
373 funds tracked by Wall St. Rank held ResMed as of Q3 2016.

Based on Veritas Asset Management's 13F filing for Q3 2016, filed 7 Nov 2016.